LIXTE Biotechnology Holdings (LIXT), a Nasdaq-listed company, has revealed its intention to allocate up to 25% of its available funds to cryptocurrencies, including Bitcoin (BTC). The company's board of directors has already approved this strategic move. The specific amount and timing of the cryptocurrency investments will be subject to careful evaluation of market conditions and other relevant factors. LIXTE believes this diversification into digital assets could potentially enhance shareholder value. This decision reflects a growing trend of publicly traded companies exploring cryptocurrency investments as a means to diversify their portfolios and potentially generate higher returns. While the exact cryptocurrencies beyond BTC haven't been specified, the move signals a significant step for LIXTE into the digital asset space. ```

#BTC